SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: contrarian who wrote (1483)2/12/1998 10:25:00 PM
From: Roger Cranwill  Read Replies (1) of 1762
 
The California state social services program (welfare program) is called Medi-Cal. The Medi-Cal bureaucracy furnishes each "health provider" with a compendium of drugs they'll pay for-most drugs are stipulated as to the exact strength, duration of action (they normally don't cover longer acting forms), and on certain drugs, specific diagnosis. What's interesting in Rituximab's case (they list all drugs by generic name only) is that no stipulation of diagnosis is listed....very interesting. Roger
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News